U.S. markets closed
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     
  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    91.88
    -2.46 (-2.61%)
     
  • Gold

    1,818.90
    +11.70 (+0.65%)
     
  • Silver

    20.83
    +0.49 (+2.39%)
     
  • EUR/USD

    1.0257
    -0.0068 (-0.66%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     
  • USD/JPY

    133.4800
    +0.4810 (+0.36%)
     
  • BTC-USD

    24,470.79
    +363.92 (+1.51%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Brazilian drugmaker Hypera's talks with rivals not currently active -source

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

By Tatiana Bautzer

SAO PAULO, July 6 (Reuters) - Brazilian pharmaceutical company Hypera has discussed a takeover offer from rival company NC Group, the owner of EMS SA, but talks are not currently active, one source with knowledge of the matter said on Wednesday.

Hypera has also discussed a sale to local pharmaceutical company Eurofarma, the source added.

Hypera's controlling shareholder, Joao Alves de Queiroz Filho, has a 21% stake in the company and a shareholder agreement with Mexican holding Maiorem SA de CV owns another 15%.

Hypera, NC Group and Eurofarma did not immediately respond to requests for comment

The source said that talks with NC Group were halted three months ago and are not currently active. The talks with Eurofarma had taken place earlier. Shares in Hypera rose 35% this year, against a 6.2% drop in the benchmark Ibovespa.

The talks were first reported by Brazilian newspaper Valor Economico, citing sources with knowledge of the matter. (Reporting by Tatiana Bautzer, Editing by Louise Heavens)